COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

NP2 Enkephalin For Treatment of Intractable Cancer Pain

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01291901
Recruitment Status : Completed
First Posted : February 9, 2011
Last Update Posted : August 8, 2014
Paragon Biomedical
invivodata, Inc.
Information provided by (Responsible Party):
Diamyd Inc

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 2012
Actual Study Completion Date : November 2013
Certification/Extension First Submitted : July 28, 2014